Press Releases - Agena Bioscience

Agena Bioscience Signs Exclusive Distribution Agreement with AGBL Group of Companies More

Wednesday, March 10th, 2021

San Diego, CA – Agena Bioscience®, the global manufacturer of the MassARRAY® System for targeted genetic analysis, today announced an exclusive distribution agreement with Alliance Global, the AGBL Group of companies...

Agena Bioscience Launches New Panel for Detection and Discrimination of SARS-CoV-2 Variants of Concern More

Monday, March 1st, 2021

San Diego, CA – Agena Bioscience^®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the MassARRAY^® SARS-CoV-2 Variant Panel (RUO) for the detection of key SARS-CoV-2...

Agena Bioscience announces high-throughput, low-cost panel for molecular detection of SARS-CoV-2, Influenza A & Influenza B More

Tuesday, December 1st, 2020

San Diego, CA – Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, today announced the launch of the MassARRAY^® SARS-CoV-2/Flu Panel (RUO) for qualitative detection of SARS-CoV-2, influenza...

Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel More

Wednesday, October 28th, 2020

San Diego, CA – Agena Bioscience, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY^® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been...

Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking More

Friday, September 25th, 2020

San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it has obtained CE-IVD marking for its SARS-CoV-2 Panel, an in vitro diagnostic test for the qualitative detection...

Agena Bioscience Announces Release of High-Throughput, Low-Cost SARS-CoV-2 Panel More

Tuesday, June 23rd, 2020

San Diego, CA - Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19. Clinical...

Agena Improves PGx Testing Accuracy with Launch of VeriDose™ CYP2D6 CNV Panel More

Quantification of Hybrid Alleles Not Detected by Common PGx Technologies San Diego, CA, November 4, 2019– Agena Bioscience, a global provider of molecular

Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis More

San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID

Agena Announces MassARRAY^® Technology Selected for Participation in CANCER-ID Consortium More

San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that it has been selected for participation

Agena and DaRui Biotechnology Announce China FDA Clearance of MassARRAY^® Technology for Diagnostic Use in China More

San Diego, CA and Guangzhou, China, Wednesdy, October 24, 2018 - Agena Bioscience (Agena) and DaRui Biotechnolog (DaRui) announced today that the MassARRAY^®

Agena Bioscience Announces Collaboration with PerkinElmer More

Combining LabChip^® GX Touch Nucleic Acid Analyzer and MassARRAY^® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena

Agena Announces MassARRAY^® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics

Agena Bioscience® in the News

Recent Press Releases